Nishar Dipchand sold $23K of SEER

Nishar Dipchand sold 10,660 shares of Seer, Inc. (SEER) at $2.18 on 2026-07-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Nishar Dipchand
Published Jul 10, 2026, 10:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 10, 2026, 10:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SEER
Neutral
high confidence
Mentioned
$SEER
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SEERNeutralLow
01

Why it matters

The newest concrete fact is the reported sale details (shares, price, total value) and confirmation that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note insider selling, but the 10b5-1 structure and lack of new company fundamentals make this more of a sentiment datapoint than a catalyst.

03

What to watch

The filing does not disclose reasons for the sale, and the transaction size is modest relative to typical institutional flows, reducing tradable signal.

Relevance 2/10Novelty 3/10Timing: Filed 2026-07-10 after the 2026-07-08 sale execution.

Background

The article is a SEC Form 4 insider transaction disclosure for Seer, Inc., reported by director Nishar Dipchand.

Company-level read

Ticker impact

$SEERNeutralHigh confidence
Context

Seer director Nishar Dipchand sold 10,660 shares on 2026-07-08 at $2.1825, totaling $23,265.45, under a 10b5-1 plan.

Expected impact

Likely minimal near-term price impact; any effect is more about sentiment than new company information.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new operating, financial, or regulatory facts about Seer.

Market effects

No clear sector read-through because the disclosure is a single-company insider sale without new guidance or events.

None indicated.

None indicated.

Counterpoint

Insider sales under 10b5-1 can reflect scheduled liquidity needs rather than bearish expectations, so the market may overreact to the headline optics.

Key entities

  • Seer, Inc.

    Company whose director insider sale is disclosed via SEC Form 4.

  • Nishar Dipchand

    Director who sold 10,660 shares on 2026-07-08 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SEERMed

Seer Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Revenue Guidance

Seer, Inc. (SEER) filed an SEC Form 8-K — Results of Operations and Financial Condition. Seer Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Revenue Guidance REDWOOD CITY, Calif. – November 10, 2026 – Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced fin

$SEERMed

Seer wins ITC staff backing for import ban on Nanomics products

Seer, Inc. (SEER) announced that the U.S. International Trade Commission's staff recommended an import ban on Nanomics' products, alleging patent infringement. The ITC is expected to make a final decision by year-end. Seer also reported recent patent victories in the U.S. and Europe. The company develops proteomics technology and is involved in a related lawsuit against Nanomics.